Tyrosine-protein phosphatase non-receptor type 1 also known as protein-tyrosine phosphatase 1B (PTP1B) is an enzyme that is the founding member of the protein tyrosine phosphatase (PTP) family. In humans it is encoded by the PTPN1 gene.[1] PTP1B is a negative regulator of the insulin signaling pathway and is considered a promising potential therapeutic target, in particular for treatment of type 2 diabetes.[2]
|
Contents
|
PTP1B was first isolated from a human placental protein extract,[3][4] but it is expressed in many tissues.[5] PTP1B is localized to the cytoplasmic face of the endoplasmic reticulum.[6] PTP1B can dephosphorylate the phosphotyrosine residues of the activated insulin receptor kinase.[4][7][8] In mice, genetic ablation of PTPN1 results in enhanced insulin sensitivity.[9][10] Several other tyrosine kinases, including epidermal growth factor receptor,[11] insulin-like growth factor 1 receptor,[12] colony stimulating factor 1 receptor,[13] c-Src,[14] Janus kinase 2,[15] TYK2,[15] and focal adhesion kinase[16] as well as other tyrosine-phosphorylated proteins, including STAT5,[17] BCAR1,[18] DOK1,[19] beta-catenin[20] and cortactin[21] have also been described as PTP1B substrates.
PTPN1 has been shown to interact with BCAR1,[18] epidermal growth factor receptor,[22][23] Grb2[18][24] and IRS1.[24][25]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||
| This article on a gene on chromosome 20 is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)